Podiatry CME

  • FREE

    Treatment of Diabetic Foot Ulcers (DFU) Using Percutaneous Ultrasonic Needle Treatment

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. While there are many complications resulting from this disease, this CME proposal focuses on treating diabetic foot ulcers that occur in the setting of peripheral neuropathy. Diabetic foot complications are the most common cause of non-traumatic foot injuries leading to amputation, and are also the most frequent reason for hospitalization in patients with diabetes in the United States Diabetic wound care treatments are varied with mixed results, and all current methods require some degree of medium to long-term follow-up and management by an interdisciplinary team which is costly and a significant burden to both the patients and the healthcare system as a whole.

    A single treatment with an ultrasonic probe has demonstrated a high rate of complete healing with low recurrence and complication rates. Using these types of devices are relatively inexpensive when compared to more extensive and complex wound care regimens and are easily learned by those experienced in managing this condition. The treatment of diabetic foot ulcers with ultrasonic probes is an evolving standard of care and is becoming an alternative to traditional treatments. This treatment involves fragmenting, emulsifying, and removing thickened scar tissue beneath the wound crater, as well as removing osseous prominences to decrease pressure on the wound bed and promote healing.

    There have been recent developments in the available treatments for diabetic foot ulcers. Communicating related information to HCPs, including recent guideline updates, is a demonstrated need.

    Target Audience:

    The following HCPs who specialize in diabetic care: Endocrinologists, podiatrists, foot and ankle surgeons, primary care physicians, physician assistants, nurse practitioners, and wound care RNs.

    See full details chevron_right
    • Cost: Free
    • Credit hours: .75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/7/2022
    • Expiration of CME credit: 9/7/2024
  • AchieveCE Preventing Medical Errors for Physicians

    This course fulfills the ACCME, Florida Board of Medicine, and Florida Physician Assistants requirement to provide medical professionals with a clearer understanding of medical errors, the devastating effects that these errors can have on both patients and health care providers, and how to use root cause analysis to identify and prevent common medical errors.

    See full details chevron_right
    • Cost: $24
    • Credit hours: 2
    • CME credits awarded by: Continuing Education Company, Inc. and AchieveCE.
    • Format: On-Demand Online
  • AchieveCE Domestic Violence for Physicians and PAs

    This course fulfills the Florida Board requirement for MDs and PAs for a domestic violence training that discusses the categories, signs and symptoms, and reporting obligations for known or suspected domestic violence cases.

    See full details chevron_right
    • Cost: $24
    • Credit hours: 2
    • CME credits awarded by: Continuing Education Company, Inc. and AchieveCE.
    • Format: On-Demand Online
  • AchieveCE Human Trafficking for Physicians and Physician Assistants

    This course is designed for healthcare professionals and those in allied professions who may come into contact with and be called upon to intervene on behalf of victims of human trafficking within the scope of their practice.

    See full details chevron_right
    • Cost: $19
    • Credit hours: 2
    • CME credits awarded by: Continuing Education Company, Inc. and AchieveCE.
    • Format: On-Demand Online
  • AchieveCE The Opioid Epidemic: Searching for Solutions Webcast

    According to the 2015 National Survey on Drug Use and Health, approximately 3.8 million people (1.4% of those ages 12 or older) reported misusing prescription pain relievers, while another 329,000 people reported using heroin. Within the same year, 52,404 lethal overdoses took place, making drug overdose the leading cause of accidental death within the United States. Stancliff et al estimated that as of 2012, approximately 80% of people dependent on heroin or prescription opioids were not engaged in any treatment and many in treatment do not use the most effective medication-assisted treatments available to them.

    Despite recent increased awareness of opioid use disorder (OUD) and efforts to improve access to care, several barriers to treatment still exist, including financial, geographic, regulatory, and social. In 2012, only 2.2% of physicians in the United States obtained waivers to prescribe buprenorphine for the treatment of OUD. Of those who received waivers, 41.6% were psychiatrists. This may be perceived as a potential barrier to OUD treatment as patients are often resistant to referrals to psychiatric and/or addiction clinics given the stigmas commonly surrounding addiction and mental health. Furthermore, physicians with waivers were found to practice primarily in urban settings, leaving a large portion of the rural population without access to buprenorphine treatment.

    With all this in mind, education is needed in regards to current and emerging treatment options for OUD available to multiple patient populations. Also, with the deaths due to drug overdoses still elevated, education on how to recognize and reverse an opioid overdose is needed.

    This presentation will address the above needs by discussing the science behind opioid use disorder as well as reflect upon current statistics associated with its impact on the United States. During the discussion, opioid overdose risks will be discussed and participants will be able to practice recognizing key symptoms of an overdose situation. Steps of using naloxone will be discussed and connected to how to appropriately seek out treatment for maintenance of opioid use disorder. Finally, new buprenorphine products and the potential role of naltrexone will be applied to this stigmatized population.

    See full details chevron_right
    • Cost: $15
    • Credit hours: 1
    • CME credits awarded by: Continuing Education Company, Inc. and AchieveCE, ACPE, AGD PACE, and ANCC
    • Format: Online Video
  • AchieveCE An Update on Pain Management Drugs for Prescribers

    This course provides 2 AMA PRA Category 1 Credit for license renewal and talks about the pharmacology, adverse effects, dosage, and administration of FDA-approved treatments for acute pain like nonopioid analgesics, adjuvant pain medications, migraine medicines, Tramadol/Celecoxib (Seglentis), Bupivacaine/Meloxicam (Zynrelef), IV Meloxicam (Anjeso), and Benzhydrocodone/Acetaminophen (Apadaz).

    See full details chevron_right
    • Cost: $24
    • Credit hours: 2
    • CME credits awarded by: The Medical Letter and AchieveCE
    • Format: On-Demand Online
  • AchieveCE Management of Reproductive Infections

    This course provides 1 AMA PRA Category 1 Credit for license renewal. Vaginal infections can cause pain and discomfort. Without treatment, they may lead to complications that can adversely affect a person’s health. From bacterial vaginosis to sexually transmitted infections, learn more about a few of the most common types of vaginal infections and symptoms here. This activity provides recommendations for the management of most sexually transmitted infections (STIs) other than HIV and viral hepatitis and FDA-approved treatments for bacterial vaginosis like Tinidazole (Tindamax) and Secnidazole (Solosec).

    See full details chevron_right
    • Cost: $19
    • CME credits awarded by: The Medical Letter and AchieveCE
    • Format: On-Demand Online
  • AchieveCE Antibiotic Treatment for Complicated UTI

    This course discusses the different FDA-approved antibiotics for the treatment of complicated urinary tract infections (UTIs). It talks about the pharmacology, clinical studies, adverse effects, dosage, and administration of Meropenem/Vaborbactam (Vabomere), Plazomicin (Zemdri), and Cefiderocol (Fetroja) for proper use.

    See full details chevron_right
    • Cost: $19
    • Credit hours: 1
    • CME credits awarded by: The Medical Letter and AchieveCE
    • Format: On-Demand Online
  • AchieveCE Breast Cancer Screening & Diagnosis

    This video activity focuses on ways to help early detection of breast cancer by learning the risk factors, the different screening and diagnostic modalities and guidelines to what kind of screening is needed, and most importantly, when should screening begin.

    See full details chevron_right
    • Cost: $19
    • Credit hours: 1
  • AchieveCE Psychological Care of Breast Cancer Patients

    From October to December, 2022, 50% of the proceeds from this course will be donated to the National Breast Cancer Foundation. Despite the advances in breast cancer detection and treatment, on the psychological side, clinicians who have been involved in the emotional care of cancer patients can report that a breast cancer diagnosis can nevertheless generate many concerns for patients, as well as their families. Psychological interventions for breast cancer patients have well-documented success in reducing distress and enhancing psychosocial adaptation to disease. As such, these interventions have been highlighted as important mechanisms by which physical health can be improved. This activity focuses on the common issues that impact psychological adjustment to breast cancer and interventions that will help optimize care in the cancer context.

    See full details chevron_right
    • Cost: $19
    • Credit hours: 1
    • Format: Online Video